Drawing for BRINTELLIX VORTIOXETINE

USPTO serial 79134889

BRINTELLIX VORTIOXETINE

Reviewed by CopyMark Law Group

Reg. 4642921Status 404
Filing date
Status date
Registration date
Nov 25, 2014
Examiner
JAGANNATHAN, SIDDHARTH
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BRINTELLIX VORTIOXETINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Claudia A. Smith

Claudia A. Smith White & Case LLP1155 Avenue of the AmericasPatent and Trademark DepartmentNew York, NY 10036

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the prevention and treatment of disorders and diseases in or affecting the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system to treat or prevent disorders and diseases in or affecting the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, depression, psychosis, anxiety, epilepsy, multiple sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, oncology, pain, alcoholism and addiction; preparations, substances, reagents and agents for diagnostic and medical purposes; all the foregoing containing in whole or substantial part vortioxetineSECTION 70 - CANCELLED—
009Scientific apparatus and instruments, namely, magnetic, electronic and optical data carriers containing information and data in the fields of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; pre-recorded audio cassettes, pre-recorded video cassettes, and electronic and digital media featuring information and data in the fields of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; downloadable electronic publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material, in the field of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; recorded computer software, namely, software for searching, storing, cataloging, and indexing medical and pharmaceutical information, indexing education and sales activities, and for enabling web-based access to websites, enabling database integration, and enabling web searching of websites, intranet and Internet; software that provides web-based access to applications and services through a web operating system or portal interface, software to provide web-based electronic storage and display of digital information in the fields of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention in the form of sounds, noises, images, graphics, animated graphics, texts, movies, and databases; data processing equipment and computers; downloadable application software for downloading information on the use of pharmaceutical products and on diseases and disorders of the central nervous system and the treatment thereof; downloadable software for games which provide information related to diseases and disorders of the central nervous system and the treatment thereof; and downloadable mobile applications for transmitting, sharing, receiving, downloading, displaying and transferring content, text, visual works, audio works, audiovisual works, literary works, data, files, documents and electronic works via portable and handheld electronic devices and computers in the fields of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and preventionSECTION 70 - CANCELLED—
010Surgical, medical, dental and veterinary apparatus and instruments; suture materials; medical apparatus and instruments for diagnostic purposes, namely, apparatus for medical diagnostic testing for diseases and disorders of the central nervous system; integrated medical examination systems comprising medical instruments, hardware and software for information and information management for use of a web-based physical and psychological examination and assessment of patients and information, guidance and control of medicinesSECTION 70 - CANCELLED—
041Educational and training services, namely, seminars, conferences, symposiums, workshops, courses, classes and lectures in the field of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments and prevention; educational and training services, namely, seminars, conferences, symposiums, workshops, courses, classes and lectures in the field of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments and prevention provided electronically, on-line, via cable or Internet or other electronic media; providing non-downloadable on-line publications, namely, books, reports, brochures, booklets, leaflets, leaflets containing patient information, magazines, journals, teaching and educational material in the field of research and development, science, clinical tests, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments and prevention; Entertainment services, namely, organizing, arranging, and conducting running, walking, golf, tennis, softball, and cycling events and cultural activitiesSECTION 70 - CANCELLED—
042Scientific and technological services, namely, scientific research, analysis and testing in the field of pharmaceuticals and research and design relating thereto; industrial research in the field of pharmaceuticals; design and development of computer hardware and software; providing a website featuring non-downloadable software that allows users to view scientific data and information in the field of research and development, science, clinical tests, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatments and prevention; pharmaceutical research and development; scientific and technological services, namely, scientific research, analysis, and testing in the field of disorders, diseases and prevention; scientific and technological services, namely, scientific research, analysis, and testing in the field of the central nervous system and central nervous system related disorders, diseases and pharmaceuticals; medical research; providing medical and clinical testing services for research purposes in the fields of central nervous system research and research on central nervous system related disorders, diseases and pharmaceuticals; providing scientific research information in the fields of central nervous system research and research on central nervous system related disorders, diseases and pharmaceuticals; providing scientific testing in the fields of central nervous system research and research on central nervous system related disorders, diseases and pharmaceuticals; providing medical and medicinal research information in the fields of central nervous system research and research on central nervous system related disorders, diseases and pharmaceuticalsSECTION 70 - CANCELLED—
044Medical services; medical services in the field of psychiatry and psychology; medical advisory and information services concerning medical and pharmaceutical preparations and substances; medical clinical services; medical treatment services; therapeutic treatment services, namely, providing therapeutic services to persons in need of treatment for conditions, disorders or diseases of the central nervous system; healthcare and medical services related to central nervous system disorders, diseases and pharmaceuticals; providing for medical and medicinal information in the field of diagnostic, medicine, medical dose, pharmaceuticals, disorders, diseases, treatments and prevention; all the aforementioned services provided off-line as well as on-lineSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 7, 2020DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Nov 7, 2020DETHDEATH OF INTERNATIONAL REGISTRATION—
Nov 25, 2019REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
May 8, 2015FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 20, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 20, 2015FIMPFINAL DISPOSITION PROCESSED—
Feb 25, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 25, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 9, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 9, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 20, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 7, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 5, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 4, 2014XAECEXAMINER'S AMENDMENT ENTERED—
Aug 4, 2014GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 4, 2014GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 4, 2014CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 30, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 30, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 30, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 12, 2014ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 12, 2014REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 24, 2014UNPRUNRESPONSIVE/DUPLICATE PAPER RECEIVED—
Apr 24, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 16, 2014TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 16, 2014PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Feb 5, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 5, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 5, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 23, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 23, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 21, 2014ALIEASSIGNED TO LIE—
Jan 8, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 30, 2013RFNTREFUSAL PROCESSED BY IB—
Sep 10, 2013MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 9, 2013RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 9, 2013RFRRREFUSAL PROCESSED BY MPU—
Sep 7, 2013RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 6, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 4, 2013DOCKASSIGNED TO EXAMINER—
Sep 4, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 3, 2013LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Aug 29, 2013REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance